NBIX
Neurocrine Biosciences Inc
Price:  
140.51 
USD
Volume:  
612,855.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NBIX Relative Valuation

-20.1%
Upside

As of 2024-05-24, the Relative Valuation of Neurocrine Biosciences Inc (NBIX) is 112.32 USD. This relative valuation is based on P/E multiples. With the latest stock price at 140.51 USD, the upside of Neurocrine Biosciences Inc based on Relative Valuation is -20.1%.

The range of the Relative Valuation is 83.74 - 156.58 USD.

Range Selected
Trailing P/E multiples 32.1x - 42.6x 38.2x
Forward P/E multiples 27.9x - 28.3x 28.1x
Fair Price 83.74 - 156.58 112.32
Upside -40.4% - 11.4% -20.1%
140.51 USD
Stock Price
112.32 USD
Fair Price

NBIX Relative Valuation - Historical P/E Data

Date P/E
2024-05-23 38.23
2024-05-22 37.93
2024-05-21 38.24
2024-05-20 38.54
2024-05-17 38.71
2024-05-16 38.61
2024-05-15 38.63
2024-05-14 37.67
2024-05-13 37.04
2024-05-10 37.19
2024-05-09 38.00
2024-05-08 37.82
2024-05-07 38.96
2024-05-06 38.55
2024-05-03 38.28
2024-05-02 38.04
2024-05-01 38.91
2024-04-30 37.42
2024-04-29 37.79
2024-04-26 37.00
2024-04-25 37.48
2024-04-24 37.81
2024-04-23 38.11
2024-04-22 36.36
2024-04-19 35.91
2024-04-18 36.06
2024-04-17 36.25
2024-04-16 36.18
2024-04-15 35.84
2024-04-12 36.64
2024-04-11 36.98
2024-04-10 37.57
2024-04-09 37.80
2024-04-08 37.94
2024-04-05 37.79
2024-04-04 37.44
2024-04-03 37.43
2024-04-02 37.47
2024-04-01 38.46
2024-03-28 37.52
2024-03-27 37.50
2024-03-26 38.40
2024-03-25 38.16
2024-03-22 38.48
2024-03-21 39.11
2024-03-20 38.27
2024-03-19 38.32
2024-03-18 37.94
2024-03-15 37.84
2024-03-14 37.86